Skip to main content
Top
Published in: Infection 3/2018

01-06-2018 | Review

Multiple small bowel perforations due to invasive aspergillosis in a patient with acute myeloid leukemia: case report and a systematic review of the literature

Authors: Gregorio Di Franco, Enrico Tagliaferri, Erica Pieroni, Edoardo Benedetti, Simone Guadagni, Matteo Palmeri, Niccolò Furbetta, Daniela Campani, Giulio Di Candio, Mario Petrini, Franco Mosca, Luca Morelli

Published in: Infection | Issue 3/2018

Login to get access

Abstract

Purpose

Invasive aspergillosis (IA) represents a major cause of morbidity and mortality in immunocompromised patients. Involvement of the gastrointestinal tract by Aspergillus is mostly reported as part of a disseminated infection from a primary pulmonary site and only rarely as an isolated organ infection.

Methods

We report a case of small bowel perforation due to IA in a patient with acute leukemia under chemotherapy and pulmonary aspergillosis. We performed a systematic review of the literature as well.

Results

A 43-year-old man with acute myeloid leukemia under chemotherapy developed severe neutropenia and pulmonary aspergillosis due to Aspergillus flavus. He developed melena and hemodynamic failure and a contrast-enhanced ultrasound scan suggested active intestinal bleeding. During emergency laparotomy we found multiple intestinal abscesses, several perforations of intestinal loop and Aspergillus flavus was isolated from the abscesses. Resection of the jejunum was performed. The patient received voriconazole and finally recovered. The patient is now alive and in complete disease remission. From literature review we found 35 intestinal IA previously published in single case reports or small case series as well.

Conclusion

Clinical manifestations of gastrointestinal aspergillosis are nonspecific, such as abdominal pain, and only occasionally it presents as an acute abdomen. Antemortem detection of bowel involvement is rarely achieved and, only in cases of complicated gastrointestinal aspergillosis, the diagnosis is achieved thanks to the findings during surgery. Gastrointestinal aspergillosis should be suspected in patients with severe and prolonged neutropenia with or without pulmonary involvement in order to consider the right therapy and prompt surgery.
Literature
1.
go back to reference Hori A, Kami M, Kishi Y, Machida U, Matsumura T, Kashima T. Clinical significance of extra-pulmonary involvement of invasive aspergillosis: a retrospective autopsy-based study of 107 patients. J Hosp Infect. 2002;50:175–82.CrossRefPubMed Hori A, Kami M, Kishi Y, Machida U, Matsumura T, Kashima T. Clinical significance of extra-pulmonary involvement of invasive aspergillosis: a retrospective autopsy-based study of 107 patients. J Hosp Infect. 2002;50:175–82.CrossRefPubMed
2.
go back to reference Cornillet A, Camus C, Nimubona S, Gandemer V, Tattevin P, Belleguic C, Chevrier S, Meunier C, Lebert C, Aupèe M, Caulet-Maugendre S, Faucheux M, Lelong B, Leray E, Guiguen C, Gangneux JP. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis. 2006;43:577–84.CrossRefPubMed Cornillet A, Camus C, Nimubona S, Gandemer V, Tattevin P, Belleguic C, Chevrier S, Meunier C, Lebert C, Aupèe M, Caulet-Maugendre S, Faucheux M, Lelong B, Leray E, Guiguen C, Gangneux JP. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis. 2006;43:577–84.CrossRefPubMed
3.
go back to reference Avcu G, Karapinar DY, Yazici P, Duyu M, Polat SH, Atabay B, Doganavsargil B, Karapinar B. Difficult diagnosis of invasive fungal infection predominantly involving the lower gastrointestinal tract in acute lymphoblastic leukaemia. Med Mycol Case Rep. 2016;11:1–4.CrossRefPubMedPubMedCentral Avcu G, Karapinar DY, Yazici P, Duyu M, Polat SH, Atabay B, Doganavsargil B, Karapinar B. Difficult diagnosis of invasive fungal infection predominantly involving the lower gastrointestinal tract in acute lymphoblastic leukaemia. Med Mycol Case Rep. 2016;11:1–4.CrossRefPubMedPubMedCentral
4.
go back to reference Eggimann P, Chevrolet J-C, Starobinski M, Majno P, Totsch M, Chapuis B, Pitted D. Primary invasive aspergillosis of the digestive tract: report of two cases and review of the literature. Infection. 2006;34:333–8.CrossRefPubMedPubMedCentral Eggimann P, Chevrolet J-C, Starobinski M, Majno P, Totsch M, Chapuis B, Pitted D. Primary invasive aspergillosis of the digestive tract: report of two cases and review of the literature. Infection. 2006;34:333–8.CrossRefPubMedPubMedCentral
6.
go back to reference Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood. 2002;100:4358–66.CrossRefPubMed Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood. 2002;100:4358–66.CrossRefPubMed
7.
go back to reference Leventakos K, Lewis RE, Kontoyiannis DP. Fungal infections in leukemia patients: how do we prevent and treat them? Clin Infect Dis. 2010;50:405–15.CrossRefPubMed Leventakos K, Lewis RE, Kontoyiannis DP. Fungal infections in leukemia patients: how do we prevent and treat them? Clin Infect Dis. 2010;50:405–15.CrossRefPubMed
8.
go back to reference Dragonetti G, Criscuolo M, Fianchi L, Pagano L. Invasive aspergillosis in acute myeloid leukemia: are we making progress in reducing mortality? Med Mycol. 2017;55:82–6.CrossRefPubMed Dragonetti G, Criscuolo M, Fianchi L, Pagano L. Invasive aspergillosis in acute myeloid leukemia: are we making progress in reducing mortality? Med Mycol. 2017;55:82–6.CrossRefPubMed
9.
go back to reference Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical Practice Guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327–60.CrossRefPubMed Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical Practice Guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327–60.CrossRefPubMed
10.
go back to reference Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63:e1–60.CrossRefPubMedPubMedCentral Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63:e1–60.CrossRefPubMedPubMedCentral
11.
go back to reference Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med. 2006;173:707–17.CrossRefPubMed Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med. 2006;173:707–17.CrossRefPubMed
12.
go back to reference Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424–47.CrossRefPubMedPubMedCentral Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424–47.CrossRefPubMedPubMedCentral
13.
go back to reference Imola M, Mianulli AM, Pasini G, Santelmo C, Drudi F, Fantini M, Corso V, Veneroni L, Ravaioli A. Emergency hemicolectomy for intestinal primary aspergillosis in acute myeloid leukemia. G Chir. 2012;33:74–6.PubMed Imola M, Mianulli AM, Pasini G, Santelmo C, Drudi F, Fantini M, Corso V, Veneroni L, Ravaioli A. Emergency hemicolectomy for intestinal primary aspergillosis in acute myeloid leukemia. G Chir. 2012;33:74–6.PubMed
14.
go back to reference Lunde LE, Chuang C, Linden MA, Williams SA, Sachs Z, Cayci Z, Young JA, Ustun C. Lethal small bowel necrosis due to aspergillosis during acute promyelocytic leukemia induction. Am J Hematol. 2013;88:329–32.CrossRefPubMed Lunde LE, Chuang C, Linden MA, Williams SA, Sachs Z, Cayci Z, Young JA, Ustun C. Lethal small bowel necrosis due to aspergillosis during acute promyelocytic leukemia induction. Am J Hematol. 2013;88:329–32.CrossRefPubMed
15.
go back to reference Ouaïssi M, Moutardier V, Emungania O, Lelong B, Forel JM, Guiramand J, Turrini O, Delpero JR. Fatal bowel infarction due to aspergillosis after chemotherapy. Eur J Surg Oncol. 2003;29:628.CrossRefPubMed Ouaïssi M, Moutardier V, Emungania O, Lelong B, Forel JM, Guiramand J, Turrini O, Delpero JR. Fatal bowel infarction due to aspergillosis after chemotherapy. Eur J Surg Oncol. 2003;29:628.CrossRefPubMed
16.
go back to reference Trésallet C, Nguyen-Thanh Q, Aubriot-Lorton M-H, Akakpo J-P, Al Jijakli A, Cardot V, Chigot JP, Menegaux F. Small-bowel infarction from disseminated aspergillosis. Dis Colon Rectum. 2004;47:1515–8.CrossRefPubMed Trésallet C, Nguyen-Thanh Q, Aubriot-Lorton M-H, Akakpo J-P, Al Jijakli A, Cardot V, Chigot JP, Menegaux F. Small-bowel infarction from disseminated aspergillosis. Dis Colon Rectum. 2004;47:1515–8.CrossRefPubMed
17.
go back to reference Kazan E, Maertens J, Herbrecht R, Weisser M, Gachot B, Vekhoff A, Caillot D, Raffoux E, Fagot T, Reman O, Isnard F, Thiebaut A, Bretagne S, Cordonnier C. A retrospective series of gut aspergillosis in haematology patients. Clin Microbiol Infect. 2011;17:588–94.CrossRefPubMed Kazan E, Maertens J, Herbrecht R, Weisser M, Gachot B, Vekhoff A, Caillot D, Raffoux E, Fagot T, Reman O, Isnard F, Thiebaut A, Bretagne S, Cordonnier C. A retrospective series of gut aspergillosis in haematology patients. Clin Microbiol Infect. 2011;17:588–94.CrossRefPubMed
18.
go back to reference Cha SA, Kim MH, Lim TS, Kim HH, Chang KY, Park HS, Kim HW, Wie SH, Jin DC. Invasive primary colonic aspergillosis in the immunocompetent host without classical risk factors. Yonsei Med J. 2015;56:1453–6.CrossRefPubMedPubMedCentral Cha SA, Kim MH, Lim TS, Kim HH, Chang KY, Park HS, Kim HW, Wie SH, Jin DC. Invasive primary colonic aspergillosis in the immunocompetent host without classical risk factors. Yonsei Med J. 2015;56:1453–6.CrossRefPubMedPubMedCentral
19.
go back to reference Bizet J, Cooper CJ, Zuckerman MJ, Torabi A, Mendoza-Ladd A. A bleeding colonic ulcer from invasive Aspergillus infection in an immunocompromised patient: a case report. J Med Case Rep. 2014;8:407.CrossRefPubMedPubMedCentral Bizet J, Cooper CJ, Zuckerman MJ, Torabi A, Mendoza-Ladd A. A bleeding colonic ulcer from invasive Aspergillus infection in an immunocompromised patient: a case report. J Med Case Rep. 2014;8:407.CrossRefPubMedPubMedCentral
20.
go back to reference Mora D, Barba P, Ruiz I, Castillo N, Aizpurua M, Roselló E, Bosch F, Valcárcel D. Primary gastrointestinal aspergillosis 6 months after allogeneic hematopoietic cell transplantation: a case report. Transpl Infect Dis. 2013;15:E107–10.CrossRefPubMed Mora D, Barba P, Ruiz I, Castillo N, Aizpurua M, Roselló E, Bosch F, Valcárcel D. Primary gastrointestinal aspergillosis 6 months after allogeneic hematopoietic cell transplantation: a case report. Transpl Infect Dis. 2013;15:E107–10.CrossRefPubMed
22.
go back to reference Choi S-H, Chung J-W, Cho SY, Kim BJ, Kwon GY. A case of isolated invasive Aspergillus colitis presenting with hematochezia in a nonneutropenic patient with colon cancer. Gut Liver. 2010;4:274–7.CrossRefPubMedPubMedCentral Choi S-H, Chung J-W, Cho SY, Kim BJ, Kwon GY. A case of isolated invasive Aspergillus colitis presenting with hematochezia in a nonneutropenic patient with colon cancer. Gut Liver. 2010;4:274–7.CrossRefPubMedPubMedCentral
23.
go back to reference Chaudhary A, Jain V, Dwivedi RS, Misra S. Invasive aspergillosis causing small bowel infarction in a patient of carcinoma breast undergoing chemotherapy. J Carcinog. 2006;5:18.CrossRefPubMedPubMedCentral Chaudhary A, Jain V, Dwivedi RS, Misra S. Invasive aspergillosis causing small bowel infarction in a patient of carcinoma breast undergoing chemotherapy. J Carcinog. 2006;5:18.CrossRefPubMedPubMedCentral
24.
go back to reference Mohite U, Kell J, Haj MA, O’Brien C, Kundu S, Rees J, Burnett AK. Invasive aspergillosis localised to the colon presenting as toxic megacolon. Eur J Haematol. 2007;78:270–3.CrossRefPubMed Mohite U, Kell J, Haj MA, O’Brien C, Kundu S, Rees J, Burnett AK. Invasive aspergillosis localised to the colon presenting as toxic megacolon. Eur J Haematol. 2007;78:270–3.CrossRefPubMed
25.
go back to reference Cohen R, Heffner JE. Bowel infarction as the initial manifestation of disseminated aspergillosis. Chest. 1992;101:877–9.CrossRefPubMed Cohen R, Heffner JE. Bowel infarction as the initial manifestation of disseminated aspergillosis. Chest. 1992;101:877–9.CrossRefPubMed
26.
go back to reference Pagano L, Caira M, Picardi M, Candoni A, Melillo L, Fianchi L, Offidani M, Nosari A. Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality–SEIFEM-C report. Clin Infect Dis. 2007;44:1524–5.CrossRefPubMed Pagano L, Caira M, Picardi M, Candoni A, Melillo L, Fianchi L, Offidani M, Nosari A. Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality–SEIFEM-C report. Clin Infect Dis. 2007;44:1524–5.CrossRefPubMed
27.
go back to reference Perkhofer S, Lass-Florl C, Hell M, Russ G, Krause R, Hönigl M, Geltner C, Auberger J, Gastl G, Mitterbauer M, Willinger B, Knöbl P, Resch G, Waldner R, Makrai A, Hartmann G, Girschikofsky M, Greil R. The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients. Int J Antimicrob Agents. 2010;36:531–6.CrossRefPubMed Perkhofer S, Lass-Florl C, Hell M, Russ G, Krause R, Hönigl M, Geltner C, Auberger J, Gastl G, Mitterbauer M, Willinger B, Knöbl P, Resch G, Waldner R, Makrai A, Hartmann G, Girschikofsky M, Greil R. The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients. Int J Antimicrob Agents. 2010;36:531–6.CrossRefPubMed
28.
go back to reference Ramos ER, Jiang Y, Hachem R, Kassis C, Kontoyiannis DP, Raad I. Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles. Oncologist. 2011;16:1049–60.CrossRefPubMedPubMedCentral Ramos ER, Jiang Y, Hachem R, Kassis C, Kontoyiannis DP, Raad I. Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles. Oncologist. 2011;16:1049–60.CrossRefPubMedPubMedCentral
29.
go back to reference Porpon R, Chen Y, Chakrabarti A, Li R, Shivaprakash R, Yu J, Yu J, Kung HC, Watcharananan S, Tan AL, Saffari SE, Tan BH. Epidemiology and clinical characteristics of invasive mould infections: a multicenter, retrospective analysis in five Asian countries. Med Mycol. 2017. https://doi.org/10.1093/mmy/myx029.CrossRef Porpon R, Chen Y, Chakrabarti A, Li R, Shivaprakash R, Yu J, Yu J, Kung HC, Watcharananan S, Tan AL, Saffari SE, Tan BH. Epidemiology and clinical characteristics of invasive mould infections: a multicenter, retrospective analysis in five Asian countries. Med Mycol. 2017. https://​doi.​org/​10.​1093/​mmy/​myx029.CrossRef
30.
go back to reference Steinbach WJ, Marr KA, Anaissie EJ, Azie N, Quan SP, Meier-Kriesche HU, Apewokin S, Horn DL. Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry. J Infect. 2012;65:453–64.CrossRefPubMed Steinbach WJ, Marr KA, Anaissie EJ, Azie N, Quan SP, Meier-Kriesche HU, Apewokin S, Horn DL. Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry. J Infect. 2012;65:453–64.CrossRefPubMed
31.
go back to reference Hsu LY, Lee DG, Yeh SP, Bhurani D, Khanh BQ, Low CY, Norasetthada L, Chan T, Kwong YL, Vaid AK, Alejandria I, Mendoza M, Chen CY, Johnson A, Tan TY. Epidemiology of invasive fungal diseases among patients with haematological disorders in the Asia-Pacific: a prospective observational study. Clin Microbiol Infect. 2015;21:594.e7–11.CrossRef Hsu LY, Lee DG, Yeh SP, Bhurani D, Khanh BQ, Low CY, Norasetthada L, Chan T, Kwong YL, Vaid AK, Alejandria I, Mendoza M, Chen CY, Johnson A, Tan TY. Epidemiology of invasive fungal diseases among patients with haematological disorders in the Asia-Pacific: a prospective observational study. Clin Microbiol Infect. 2015;21:594.e7–11.CrossRef
32.
go back to reference Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, Bow EJ, Rahav G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz WJ, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Selleslag D, Shoham S, Thompson GR 3rd, Lee M, Maher RM, Schmitt-Hoffmann AH, Zeiher B, Ullmann AJ. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. Lancet. 2016;387:760–9.CrossRefPubMed Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, Bow EJ, Rahav G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz WJ, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Selleslag D, Shoham S, Thompson GR 3rd, Lee M, Maher RM, Schmitt-Hoffmann AH, Zeiher B, Ullmann AJ. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. Lancet. 2016;387:760–9.CrossRefPubMed
33.
go back to reference Karaman I, Karaman A, Boduroğlu EC, Erdoğan D, Tanır G. Invasive Aspergillus infection localized to the gastric wall: report of a case. Surg Today. 2013;43:682–4.CrossRefPubMed Karaman I, Karaman A, Boduroğlu EC, Erdoğan D, Tanır G. Invasive Aspergillus infection localized to the gastric wall: report of a case. Surg Today. 2013;43:682–4.CrossRefPubMed
34.
go back to reference Jayshree RS, Shafiulla M, George J, David JK, Bapsy PP, Chakrabarti A. Microscopic, cultural and molecular evidence of disseminated invasive aspergillosis involving the lungs and the gastrointestinal tract. J Med Microbiol. 2006;55:961–4.CrossRefPubMed Jayshree RS, Shafiulla M, George J, David JK, Bapsy PP, Chakrabarti A. Microscopic, cultural and molecular evidence of disseminated invasive aspergillosis involving the lungs and the gastrointestinal tract. J Med Microbiol. 2006;55:961–4.CrossRefPubMed
35.
go back to reference Catalano L, Picardi M, Anzivino D, Insabato L, Notaro R, Rotoli B. Small bowel infarction by Aspergillus. Haematologica. 1997;82:182–3.PubMed Catalano L, Picardi M, Anzivino D, Insabato L, Notaro R, Rotoli B. Small bowel infarction by Aspergillus. Haematologica. 1997;82:182–3.PubMed
36.
go back to reference McCarthy M, Petraitiene R, Walsh T. Translational development and application of (1 → 3)-β-d-glucan for diagnosis and therapeutic monitoring of invasive mycoses. Int J Mol Sci. 2017;18:1124.CrossRefPubMedCentral McCarthy M, Petraitiene R, Walsh T. Translational development and application of (1 → 3)-β-d-glucan for diagnosis and therapeutic monitoring of invasive mycoses. Int J Mol Sci. 2017;18:1124.CrossRefPubMedCentral
37.
go back to reference Yong S, Attal H, Chejfec G. Pseudomembranous gastritis: a novel complication of Aspergillus infection in a patient with a bone marrow transplant and graft versus host disease. Arch Pathol Lab Med. 2000;124:619–24.PubMed Yong S, Attal H, Chejfec G. Pseudomembranous gastritis: a novel complication of Aspergillus infection in a patient with a bone marrow transplant and graft versus host disease. Arch Pathol Lab Med. 2000;124:619–24.PubMed
38.
go back to reference Sulahian A, Porcher R, Bergeron A, Touratier S, Raffoux E, Menotti J, Derouin F, Ribaud P. Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis. J Clin Microbiol. 2014;52:2328–33.CrossRefPubMedPubMedCentral Sulahian A, Porcher R, Bergeron A, Touratier S, Raffoux E, Menotti J, Derouin F, Ribaud P. Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis. J Clin Microbiol. 2014;52:2328–33.CrossRefPubMedPubMedCentral
39.
go back to reference Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann J-W, et al. Voriconazole versus Amphotericin B for primary therapy of invasive Aspergillosis. N Engl J Med. 2002;347:408–15.CrossRefPubMed Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann J-W, et al. Voriconazole versus Amphotericin B for primary therapy of invasive Aspergillosis. N Engl J Med. 2002;347:408–15.CrossRefPubMed
40.
go back to reference Denning DW, Marr KA, Lau WM, Facklam DP, Ratanatharathorn V, Becker C, et al. Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis. J Infect. 2006;53:337–49.CrossRefPubMed Denning DW, Marr KA, Lau WM, Facklam DP, Ratanatharathorn V, Becker C, et al. Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis. J Infect. 2006;53:337–49.CrossRefPubMed
Metadata
Title
Multiple small bowel perforations due to invasive aspergillosis in a patient with acute myeloid leukemia: case report and a systematic review of the literature
Authors
Gregorio Di Franco
Enrico Tagliaferri
Erica Pieroni
Edoardo Benedetti
Simone Guadagni
Matteo Palmeri
Niccolò Furbetta
Daniela Campani
Giulio Di Candio
Mario Petrini
Franco Mosca
Luca Morelli
Publication date
01-06-2018
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 3/2018
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-018-1115-7

Other articles of this Issue 3/2018

Infection 3/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.